Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma

ClinicalTrials.gov ID: NCT00193492

Public ClinicalTrials.gov record NCT00193492. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 11, 2026, 8:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Rituximab +/- Bevacizumab in the Treatment of Patients With Follicular Non-Hodgkin's Lymphoma: A Randomized, Phase II Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the feasibility, efficacy and safety of adding bevacizumab to rituximab compared to rituximab alone in patients with previously treated follicular non-hodgkin's lymphoma (NHL) whose disease has progressed following at least one previous chemotherapy regimen and not more than 2 previous chemotherapy regimens.

Study identification

NCT ID
NCT00193492
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
60 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2005 (Type not available)
Primary completion
Mar 2013 (Actual)
Completion
Mar 2013 (Actual)
Last update posted
Jan 5, 2015

2005 – 2013

United States locations

U.S. sites
22
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Northeast Arkansas Clinic Jonesboro Arkansas 72401 —
Florida Cancer Specialists Fort Myers Florida 33901 —
Integrated Community Oncology Network Jacksonville Florida 32256 —
Watson Clinic for Cancer Research Lakeland Florida 33805 —
Florida Hospital Cancer Institute Orlando Florida 32804 —
Medical Oncology Associates of Augusta Augusta Georgia 30901 —
Northeast Georgia Medical Center Gainesville Georgia 30501 —
Wellstar Cancer Research Marietta Georgia 30060 —
Providence Medical Group Terre Haute Indiana 47802 —
Graves-Gilbert Clinic Bowling Green Kentucky 42101 —
Baptist Hospital East Louisville Kentucky 40207 —
Norton Cancer Institute Louisville Kentucky 40207 —
Hematology Oncology Clinic, LLP Baton Rouge Louisiana 70809 —
Center for Cancer and Blood Disorders Bethesda Maryland 20817 —
National Capital Clinical Research Consortium Bethesda Maryland 20817 —
Methodist Cancer Center Omaha Nebraska 68114 —
Hematology Oncology Associates of Northern NJ Morristown New Jersey 07960 —
Oncology Hematology Care Cincinnati Ohio 45242 —
Berks Hematology Oncology Associates West Reading Pennsylvania 19611 —
Spartanburg Regional Medical Center Spartanburg South Carolina 29303 —
Chattanooga Oncology Hematology Associates Chattanooga Tennessee 37404 —
Tennessee Oncology, PLLC Nashville Tennessee 37023 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00193492, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 5, 2015 · Synced Oct 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00193492 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →